|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 105, 541-549, Copyright © 1993 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
XH Ning, X Ding, KF Childs, SF Bolling and KP Gallagher
The effects of flavone (2-phenyl-1,4-benzopyrone), a modulator of the
cytochrome P-450 monooxygenase system, on myocardial postischemic
reperfusion recovery were examined in the present study. Left ventricular
functional recovery was evaluated in isolated, crystalloid- perfused rabbit
hearts after 2 hours of modestly hypothermic (34 degrees C) global
ischemia. Four groups (n = 8 in each group) were studied and compared: a
vehicle control group, a second group pretreated with flavone (8 x 10(-6)
mol/L) before ischemia, a third group pretreated with flavone followed by
SKF 525-A (1.7 x 10(-5) mol/L), an inhibitor of cytochrome P-450, and a
fourth group pretreated with flavone followed by indomethacin (1 x 10(-6)
mol/L), an inhibitor of cyclooxygenase. At 15, 30, and 45 minutes after
reperfusion, recovery of left ventricular developed pressure in the control
group averaged (mean +/- standard deviation) only 2.60% +/- 12.7%, 35.5%
+/- 15.0%, and 42.9% +/- 13.5% of baseline, respectively. In the flavone-
treated group, recovery was significantly better, averaging 67.7% +/-
10.7%, 73.9% +/- 9.3%, and 73.6% +/- 7.6% of baseline at the same time
periods. Recovery of peak positive rate of pressure rise in the control
group averaged 27.4% +/- 15.2%, 38.6% +/- 19.2%, and 45.4% +/- 18.6% of
baseline at 15, 30, and 45 minutes of reperfusion, respectively. In the
flavone-treated group recovery values were significantly higher, averaging
67.8% +/- 9.6%, 77.3% +/- 8.5%, and 77.0% +/- 9.0% of baseline.
End-diastolic pressures were significantly lower in the flavone-treated
group compared with the control group at all reperfusion time points.
Myocardial oxygen consumption was significantly higher in the
flavone-treated group at 30 and 45 minutes of reperfusion, as well. The
improvement resulting from flavone infusion was abolished completely by SKF
525-A, providing support for the interpretation that the effects of flavone
were mediated through the cytochrome P-450 system. The cyclooxygenase
inhibitor indomethacin midly attenuated the effects of flavone
pretreatment, suggesting that the effects of flavone were only minimally
related to metabolites of cyclooxygenase. We conclude that pretreatment
with flavone represents a promising approach to myocardial protection that
may be due to modulation of the myocardial cytochrome P-450 system.
ARTICLES
Flavone improves functional recovery after ischemia in isolated reperfused rabbit hearts
Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor.
This article has been cited by other articles:
![]() |
E. Middleton Jr., C. Kandaswami, and T. C. Theoharides The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer Pharmacol. Rev., December 1, 2000; 52(4): 673 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Ning, C.-S. Xu, Y. C. Song, Y. Xiao, Y.-J. Hu, F. M. Lupinetti, and M. A. Portman Hypothermia preserves function and signaling for mitochondrial biogenesis during subsequent ischemia Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H786 - H793. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Ning, S.-H. Chen, C.-S. Xu, L. Li, L. Y. Yao, K. Qian, J. J. Krueger, O. M. Hyyti, and M. A. Portman Molecular Biology of Thermoregulation: Selected Contribution: Hypothermic protection of the ischemic heart via alterations in apoptotic pathways as assessed by gene array analysis J Appl Physiol, May 1, 2002; 92(5): 2200 - 2207. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |